2011
DOI: 10.3109/09273948.2011.619680
|View full text |Cite
|
Sign up to set email alerts
|

Central Serous Chorioretinopathy Associated with Topical Latanoprost Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
12
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 4 publications
0
12
1
Order By: Relevance
“…10 Interestingly, both patients were on chronic latanoprost in both eyes for glaucoma treatment, which has been associated with CSCR-like pathology that improves following cessation of topical prostaglandin. [11][12][13][14] However, unlike our cases reported here, these cases documented leakage on FA and did not report outer retinal thickening. Our patients improved following antiviral therapy without cessation of their prostaglandin medication.…”
Section: Discussioncontrasting
confidence: 79%
“…10 Interestingly, both patients were on chronic latanoprost in both eyes for glaucoma treatment, which has been associated with CSCR-like pathology that improves following cessation of topical prostaglandin. [11][12][13][14] However, unlike our cases reported here, these cases documented leakage on FA and did not report outer retinal thickening. Our patients improved following antiviral therapy without cessation of their prostaglandin medication.…”
Section: Discussioncontrasting
confidence: 79%
“…Although central serous chorioretinopathy has been reported in association with latanoprost use, administration of latanoprost in our patient achieved IOP reduction without concurrent worsening of visual acuity, macular edema or subretinal fluid. 13 In eyes refractory to conservative management, surgical intervention may be required with intraoperative measures to reduce the risk of intraoperative or postoperative choroidal effusion. 11 , 12 …”
Section: Discussionmentioning
confidence: 99%
“… 11 Macular edema along with NSD has been reported concurrently in only two patients on topical Latanoprost therapy but both of these patients had undergone complicated cataract surgeries and the presence of edema could have been attributed to this risk factor. 8 , 9 Since our patient had uncontrolled IOP on maximum therapy, we could not stop eye drop Travoprost despite the rare association of NSD with Travoprost. However, we could discontinue the drop after successful filtering surgery, so we cannot conclusively pinpoint the association of NSD with macular edema with Travoprost in our patient.…”
Section: Discussionmentioning
confidence: 94%
“…Although very few case reports suggest the same and that too no similar cases have been reported with Travoprost 0.004%. 8 10 Travoprost has been associated with NSD only in a single case report and the edema resolved on stopping the presumed offending drug. 11 Macular edema along with NSD has been reported concurrently in only two patients on topical Latanoprost therapy but both of these patients had undergone complicated cataract surgeries and the presence of edema could have been attributed to this risk factor.…”
Section: Discussionmentioning
confidence: 99%